Navigation Links
Salk Welcomes National Leader in Academic Technology Transfer
Date:3/4/2011

LA JOLLA, Calif., March 4, 2011 /PRNewswire-USNewswire/ -- The Salk Institute is pleased to announce the appointment of Robert MacWright, Ph.D., Esq. as Executive Director of the Salk Institute Office of Technology Development. His appointment begins February 14, 2011.

Dr. MacWright has extensive experience in academic technology transfer.  For over a decade he was Executive Director of the University of Virginia Patent Foundation, where he led a broad expansion and modernization of its patent and licensing activities. He also led the creation of a subsidiary that supported faculty start-up companies, and the creation of a local angel investment fund.  He previously led the creation and development of technology transfer programs at Rutgers University, and served as Executive Director of the Rutgers University Office of Corporate Liaison and Technology Transfer.

"Robert's strategic and academic experience will be a huge asset to the Salk," said William R. Brody, President, Salk Institute.  "His deep understanding of basic research, academia and industry is unique and he is poised to take our Technology Transfer to new heights."

Dr. MacWright brings expertise as a patent lawyer, having practiced law at Kenyon & Kenyon, at Skadden, Arps, Slate Meagher & Flom, and at Frommer Lawrence & Haug.  He holds a Ph.D. in biochemistry from Rutgers University and the University of Medicine & Dentistry of New Jersey.  He has academic and industry research experience in protein chemistry and molecular genetics. He holds a law degree from The Rutgers School of Law in Newark.

"The Office of Technology Management and Development plays a significant role in Salk's ability to advance basic research into the marketplace.  Robert's energy and advocacy come at a crucial time. We look forward to his leadership," said Marsha Chandler, Executive Vice President, Salk Institute.

About the Salk Institute for Biological Studies:

The Salk Institute for Biological Studies is one of the world's preeminent basic research institutions, where internationally renowned faculty probe fundamental life science questions in a unique, collaborative, and creative environment. Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer's, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology, and related disciplines.

Faculty achievements have been recognized with numerous honors, including Nobel Prizes and memberships in the National Academy of Sciences. Founded in 1960 by polio vaccine pioneer Jonas Salk, M.D., the Institute is an independent nonprofit organization and architectural landmark.Media Contacts:Kat Kearney858-453-4100x1226kkearney@salk.eduThis news release was issued on behalf of Newswise(TM).  For more information, visit http://www.newswise.com.


'/>"/>
SOURCE Salk Institute for Biological Studies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory
2. Association of Clinical Research Organizations (ACRO) Welcomes Clinilabs and RPS as New Members
3. Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers
4. Desert Radiologists Welcomes Five New Physicians to the Practice
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
7. Spring Point Project Welcomes Second Generation Medical-Grade Piglets
8. Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology
9. Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program
10. Vineland Welcomes Dr. Isabelle Lesschaeve as Research Chair, Sensory and Consumer Sciences
11. South Africas Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... and CEO, Jim Joyce . In ... Saturday, Bill Gates warned world leaders that ... nuclear weapons. Mr. Gates expressed his concern, which is ... scientific terrorists have access to the necessary tools to ...
(Date:2/24/2017)... , ... February 24, 2017 , ... FireflySci, Inc is ... in late 2014, FireflySci had the goal of bringing their powerful cuvette ... to shape the path that FireflySci is going on as they add yet another ...
(Date:2/23/2017)... and NEW YORK ... HIMSS, Lumeon , a leading digital health ... Telehealth), a provider of telemedicine and remote patient ... pathways for telemedicine reimbursements.  DN ... their patients, in real-time, extending consultations beyond a ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
Breaking Biology Technology:
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
(Date:2/3/2017)... WASHINGTON , Feb. 3, 2017 A ... Identity Strategy Partners, LLP (IdSP) . Designed to ... in the complex identity market, founding partners Mark ... nearly 35 combined years just in identity expertise that ... tank and non-profit leadership. The Crego-Kephart combined expertise has ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):